SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. (NYSE: KCI) today announced its subsidiary LifeCell has been granted CE Mark approval by the Netherlands-based notified body, KEMA, for its ...

LifeCell (Branchburg, New Jersey), a subsidiary of Kinetic Concepts (KCI; San Antonio) reported that the LifeCell Strattice reconstructive tissue matrix achieved highly favorable one-year outcomes in ...

LifeCell hasn’t lost any of its ambition. The Branchburg company has gone from building a niche in the hernia market to becoming a dominant player in the breast reconstruction business. And now, ...

In the first week of December Acelity pulled its IPO, and now it is clear why. The private equity-owned woundcare group has sold its Lifecell unit to Allergan (AGN) for $2.9bn in cash, allowing ...

June 13 (Reuters) - LifeCell Corp. , which provides human tissue for surgical procedures, said it received marketing approval for its soft tissue repair product, Strattice, from the U.S. Food and Drug ...

Allergan has rounded off a particularly acquisitive 2016 – even by its own standards – with a $2.9bn deal to buy US regenerative medicine specialist LifeCell. While most of the dozen deals Allergan ...

CHICAGO (Reuters) - Medical device maker Kinetic Concepts Inc said on Monday it would buy tissue repair company LifeCell for $1.7 billion to expand and diversify its product line, sending Kinetic ...

San Antonio medical technology company Acelity LP Inc. announced Tuesday it is selling LifeCell, its regenerative medicine business, to pharmaceutical giant Allergan for $2.9 billion in cash. The sale ...

SAN ANTONIO--(BUSINESS WIRE)--Acelity L.P. today announced a definitive agreement with Allergan for the acquisition of Acelity’s LifeCell business unit for $2.9 billion in cash. Upon completion of the ...